Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The device effectively and safely increased hair growth in people with Androgenetic Alopecia.

Trigonelline nanocrystal cream effectively promotes hair growth and may reduce side effects.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

GFC improves hair quickly, while PRP offers longer-lasting benefits; using both sequentially is recommended.

The TrichoScan method effectively measures hair growth and helps choose patients for hair restoration surgery.

The RNA AL136131.3 slows down hair growth and speeds up hair loss by affecting sugar breakdown in hair follicles.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

PRP can help treat hair loss but needs standardized methods for best results.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Hair loss in young men in Central India is linked to severe heart disease.

No strong proof that platelet-rich plasma effectively treats hair loss.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Micro-grafts improved hair growth in patients with hair loss.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Two specific genetic markers increase the risk of hair loss in Asian populations.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

New methods reliably assess hair regrowth and scalp health in hair loss patients.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Higher alarin levels might link hair loss and metabolic syndrome.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

European guideline best for treating hair loss; involve stakeholders and patients for improvement.